These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 33411003

  • 1. Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study.
    Zullo AR, Lee Y, Lary C, Daiello LA, Kiel DP, Berry SD.
    Osteoporos Int; 2021 Mar; 32(3):565-573. PubMed ID: 33411003
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inpatient zoledronic acid in older hip fracture patients is well tolerated and safe.
    Malgo F, van Deudekom FJA, Hup R, Formijne Jonkers HA, Kempen DHR, de Vries K, Willems HC, Vlug AG.
    Arch Osteoporos; 2024 Oct 10; 19(1):96. PubMed ID: 39388042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Denosumab versus zoledronic acid in elderly patients after hip fracture.
    Kim SJ, Kim JW, Lee DW.
    J Orthop Surg (Hong Kong); 2022 Oct 10; 30(3):10225536221147082. PubMed ID: 36541833
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.
    Lyu H, Zhao SS, Yoshida K, Tedeschi SK, Xu C, Nigwekar SU, Leder BZ, Solomon DH.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5611-5620. PubMed ID: 31265071
    [Abstract] [Full Text] [Related]

  • 12. Zoledronic acid for hip fracture during initial hospitalization.
    Fan W, Sun X, Leder BZ, Lee H, Ly TV, Pu CT, Franco-Garcia E, Bolster MB.
    J Bone Miner Res; 2024 Aug 21; 39(8):1061-1070. PubMed ID: 38952014
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study.
    Dito G, Lugaresi M, Degradi C, Guabello G, Longhi M, Corbetta S.
    Endocrine; 2023 Oct 21; 82(1):181-189. PubMed ID: 37402061
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ, Cheng LI, Allen C, O'Shea T, Stolshek B.
    J Am Med Dir Assoc; 2015 Apr 21; 16(4):341-8. PubMed ID: 25726417
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of teriparatide, denosumab and zoledronate on hip structural and mechanical parameters in osteoporosis; a real-life study.
    Jaarah N, Lam CFJ, Lodhia N, Dulnoan D, Moore AE, Hampson G.
    J Endocrinol Invest; 2024 Jul 21; 47(7):1667-1677. PubMed ID: 38191946
    [Abstract] [Full Text] [Related]

  • 16. Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study.
    Choi NK, Solomon DH, Tsacogianis TN, Landon JE, Song HJ, Kim SC.
    J Bone Miner Res; 2017 Mar 21; 32(3):611-617. PubMed ID: 27736041
    [Abstract] [Full Text] [Related]

  • 17. Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study.
    Lee H, Jin Y, Roh M, Tsacogianis TN, Park S, Choi NK, Kim SC.
    Drugs Aging; 2020 Apr 21; 37(4):311-320. PubMed ID: 32026309
    [Abstract] [Full Text] [Related]

  • 18. Polypharmacy in Osteoporosis Treatment.
    McConnell M, Shieh A.
    Clin Geriatr Med; 2022 Nov 21; 38(4):715-726. PubMed ID: 36210087
    [Abstract] [Full Text] [Related]

  • 19. Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Modi A, Sajjan S, Insinga R, Weaver J, Lewiecki EM, Harris ST.
    Osteoporos Int; 2017 Apr 21; 28(4):1355-1363. PubMed ID: 28058444
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis.
    Sheedy KC, Camara MI, Camacho PM.
    Endocr Pract; 2015 Mar 21; 21(3):275-9. PubMed ID: 25370317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.